Lisinopril Cost in Colorado 2026: Cash Price, Medicaid, Insurance & Discount Options

At a glance
- Cash price (retail, Colorado) / ~$8/month in 2026
- Manufacturer list price / ~$50/month
- Compounded lisinopril (503A pharmacy) / $0 out-of-pocket when covered; contact pharmacy for cash price
- Colorado Medicaid coverage / Yes, for hypertension, heart failure, and CKD indications
- Telehealth prescribing / Legal and widely available in Colorado
- Compounded lisinopril legality / Legal via licensed 503A compounding pharmacies in Colorado
- Standard dosing / Once daily oral tablet (5 mg to 40 mg depending on indication)
- FDA approval status / Approved; first approved 1987 for hypertension
- Common discount programs / GoodRx, RxSaver, NeedyMeds, manufacturer patient-assistance
- 90-day supply savings / Often reduces per-pill cost by 10 to 25% at major Colorado chains
What Does Lisinopril Actually Cost in Colorado in 2026?
Generic lisinopril is one of the least expensive prescription drugs available at Colorado pharmacies. The average cash-pay price across Colorado retail locations in 2026 is approximately $8 per month for a standard 30-day supply at common doses (10 mg or 20 mg once daily). The manufacturer list price sits near $50 per month, but almost no patient pays that figure because generic competition has driven retail pricing far below it.
Prices vary by pharmacy, dose, and quantity. A 90-day supply typically costs $18 to $22 cash at major Colorado chains such as King Soopers, Walgreens, and Walmart Pharmacy, which translates to roughly $6 to $7.33 per month. Independent compounding pharmacies in Colorado that hold a 503A license can prepare lisinopril formulations for patients with documented medical need, sometimes at no out-of-pocket cost when paired with specific coverage arrangements.
Lisinopril belongs to the angiotensin-converting enzyme (ACE) inhibitor drug class and has been a first-line antihypertensive agent since the FDA approved it in 1987 [1]. Its decades-long generic availability is the primary reason prices remain so low. The ALLHAT trial (N=33,357, published in JAMA 2002) compared lisinopril head-to-head with chlorthalidone and amlodipine across high-risk hypertensive patients and confirmed lisinopril's cardiovascular outcome profile, cementing its place on every major formulary [2].
Dose affects price modestly. A 40 mg tablet costs marginally more than a 10 mg tablet, but the difference at cash-pay retail is usually under $2 per month at common Colorado pharmacy chains.
How Colorado Medicaid Covers Lisinopril
Colorado Medicaid (Health First Colorado) covers generic lisinopril on its preferred drug list for enrollees diagnosed with hypertension, heart failure, or chronic kidney disease (CKD). Coverage is not restricted to patients with type 2 diabetes, meaning most enrollees who receive a valid prescription for any of those three indications can access lisinopril at low or zero cost-sharing depending on their Medicaid plan tier.
Health First Colorado members typically pay $0 to $3 per prescription for preferred generic drugs. Lisinopril consistently lands on the preferred tier because it is both inexpensive and supported by outcome data from trials such as ALLHAT [2]. Members should confirm their specific managed-care plan formulary, as Colorado Medicaid contracts with multiple Regional Accountable Entities and each may manage its drug list slightly differently.
Prior authorization is not generally required for lisinopril under Colorado Medicaid at standard doses. Doses above 40 mg daily or off-label uses may require documentation. The Colorado Department of Health Care Policy and Financing (HCPF) publishes its preferred drug list at cohcpf.org, and the list is updated quarterly.
Patients who recently lost employer coverage and are transitioning to Medicaid can request a temporary emergency supply at most Colorado pharmacies while their Medicaid enrollment processes. Colorado law allows pharmacists to dispense a 72-hour emergency supply of a maintenance drug such as lisinopril during coverage gaps [3].
Which Private Insurance Plans in Colorado Cover Lisinopril?
Every major private insurer operating in Colorado covers generic lisinopril, typically on Tier 1 (lowest cost-sharing tier) of the formulary. Connect for Health Colorado, the state's ACA marketplace, lists plans from Anthem, Kaiser Permanente Colorado, Cigna, and Denver Health Medical Plan, and all place generic lisinopril on their preferred generic tier.
Tier 1 copays for generic drugs on ACA marketplace plans in Colorado ranged from $0 to $15 per 30-day fill in 2025 plan years, with similar structures expected in 2026. Employer-sponsored plans generally mirror this; a 2023 Kaiser Family Foundation survey found that 93% of covered workers had access to a generic drug tier with a median copay of $5 [4].
Step therapy is rarely required for lisinopril because it is itself a first-line agent. However, some Colorado Medicare Part D plans place it on Tier 2 instead of Tier 1, which can raise the cost to $10 to $20 per fill. Patients on Medicare Part D should use Medicare's Plan Finder tool at medicare.gov to compare formulary tiers before enrollment or during the annual open enrollment period (October 15 to December 7).
Medicare Advantage plans offered by Kaiser Permanente Colorado, Humana, and UnitedHealthcare all included lisinopril on their 2025 preferred generic tiers, with $0 or $5 copays at preferred network pharmacies. Those structures carry forward into 2026 plan years for most enrollees.
Is Compounded Lisinopril Legal in Colorado?
Compounded lisinopril is legal in Colorado when prepared by a pharmacy holding a valid 503A license under the federal Drug Quality and Security Act. A 503A compounding pharmacy fills patient-specific prescriptions written by a licensed practitioner and is regulated by both the Colorado State Board of Pharmacy and the FDA [5].
503A compounding is appropriate for patients who have a documented clinical need that cannot be met by the commercially available tablet, such as a requirement for an oral liquid formulation (common in pediatric or swallowing-impaired patients), or a need to exclude a specific inactive ingredient due to allergy. Colorado-licensed 503A pharmacies can ship compounded lisinopril to patients within the state.
503B outsourcing facilities, which manufacture larger sterile or non-sterile batches without patient-specific prescriptions, cannot legally compound lisinopril at the time of this article because lisinopril is not on FDA's 503B bulks list and is commercially available in sufficient supply [5]. Patients and prescribers should confirm facility licensure status before ordering any compounded formulation.
The Colorado State Board of Pharmacy maintains a public licensee lookup at colorado.gov/dora/pharmacy, where anyone can verify whether a compounding pharmacy holds an active 503A license.
Can You Get a Lisinopril Prescription via Telehealth in Colorado?
Yes. Colorado law permits licensed physicians, nurse practitioners, and physician assistants to prescribe lisinopril via synchronous telehealth (live video) and, in many cases, asynchronous (store-and-forward) encounters. Lisinopril is not a controlled substance, so it does not carry the additional prescribing restrictions that apply to Schedule II through IV drugs.
Colorado joined the Interstate Medical Licensure Compact (IMLC) and the Nurse Licensure Compact (NLC), meaning clinicians licensed in other compact states can often prescribe to Colorado patients without obtaining a separate Colorado license. This has expanded the pool of telehealth providers serving Colorado residents substantially since 2021.
Telehealth prescribing of antihypertensives including lisinopril is consistent with current American Heart Association guidance, which supports remote monitoring and telehealth management of hypertension as an evidence-based strategy for improving blood pressure control rates [6]. A 2022 meta-analysis in the Journal of the American Heart Association (JAHA) covering 13 randomized trials (N=5,110) found that telehealth-delivered hypertension management reduced systolic blood pressure by a mean of 7.4 mmHg compared with usual care (P<0.001) [7].
Patients using HealthRX or similar platforms can receive a lisinopril prescription after an intake questionnaire, blood pressure review, and a live or asynchronous clinician visit. The prescription routes to a pharmacy of the patient's choice, including mail-order pharmacies that can deliver to any Colorado address.
What Is the Cheapest Way to Get Lisinopril in Colorado?
Several strategies reliably reduce the out-of-pocket cost of lisinopril in Colorado below the already-low cash price of $8 per month.
Discount cards and coupon programs. GoodRx, RxSaver, and Blink Health all show lisinopril prices of $4 to $9 per 30-day supply at major Colorado pharmacies as of early 2026. These prices are available to anyone regardless of insurance status, and using a discount card is legal; the pharmacist simply applies the card's negotiated rate instead of the cash price. Patients cannot use a discount card simultaneously with Medicaid or Medicare Part D, but uninsured or underinsured patients benefit significantly.
Walmart $4/$10 generic list. Walmart Pharmacy in Colorado participates in its $4 (30-day) and $10 (90-day) generic program. Lisinopril at 5 mg, 10 mg, 20 mg, and 40 mg is included on this list. A patient paying out of pocket who fills a 90-day supply at Walmart pays $10 total, or approximately $3.33 per month.
90-day mail-order fills. Most Colorado insurance plans allow 90-day mail-order fills at reduced copays. Patients on Anthem, Kaiser, or Cigna plans in Colorado often pay one copay for three months of medication when using the plan's preferred mail-order pharmacy.
Manufacturer patient-assistance programs. Because lisinopril is generic, there is no branded manufacturer program. However, NeedyMeds.org lists state and federal programs available to Colorado residents who fall below 200% of the federal poverty level, including assistance with pharmacy costs through the Colorado Indigent Care Program and various county health programs.
ADAP / Ryan White for HIV-positive patients. Colorado's AIDS Drug Assistance Program (ADAP) covers antihypertensives including lisinopril for qualifying HIV-positive patients who meet income thresholds, at no cost to the patient.
The table below summarizes approximate 2026 monthly costs under different access pathways in Colorado:
| Access Pathway | Estimated Monthly Cost | |---|---| | Cash pay, retail pharmacy | ~$8 | | Walmart $4 generic program (30-day) | $4 | | Walmart $10 generic program (90-day) | ~$3.33 | | GoodRx / discount card | $4 to $9 | | Colorado Medicaid (preferred tier) | $0 to $3 | | Medicare Part D (Tier 1) | $0 to $5 | | Medicare Part D (Tier 2) | $10 to $20 | | ACA marketplace plan (Tier 1 generic) | $0 to $15 | | 503A compounded formulation (cash) | Varies by pharmacy; contact directly |
What the Clinical Evidence Says About Lisinopril's Effectiveness
Understanding why lisinopril is on every formulary matters when patients are deciding whether a small cost difference between drug classes is worth switching. The evidence base is extensive.
ALLHAT, the largest antihypertensive trial ever conducted (N=33,357), compared lisinopril to chlorthalidone and amlodipine over a mean follow-up of 4.9 years in patients with stage 1 or 2 hypertension plus at least one additional cardiovascular risk factor. Chlorthalidone performed slightly better on combined cardiovascular outcomes in that specific population, but lisinopril produced equivalent rates of fatal coronary heart disease and non-fatal myocardial infarction (relative risk 0.99 to 95% CI 0.91 to 1.08) [2]. The American College of Cardiology/American Heart Association (ACC/AHA) 2017 hypertension guideline, which sets targets of below 130/80 mmHg for most adults, lists ACE inhibitors including lisinopril as a first-line option alongside thiazides, calcium channel blockers, and ARBs [6].
For heart failure with reduced ejection fraction (HFrEF), lisinopril and other ACE inhibitors reduce all-cause mortality by approximately 17% compared with placebo, based on a Cochrane systematic review of 23 trials (N=22,990) [8]. The FDA-approved label for lisinopril in heart failure is supported by the ATLAS trial, which compared low-dose (2.5 to 5 mg) versus high-dose (32.5 to 35 mg) lisinopril and found that high-dose therapy reduced the risk of death or hospitalization by 12% (P<0.002) [9].
For diabetic nephropathy and CKD, ACE inhibitors reduce proteinuria and slow the decline in glomerular filtration rate. The Lewis trial (N=409) showed that captopril reduced the risk of doubling serum creatinine, end-stage renal disease, or death by 50% in patients with type 1 diabetes and nephropathy [10]. Lisinopril carries similar nephroprotective evidence and is preferred by the American Diabetes Association's Standards of Medical Care for patients with diabetes and albuminuria [11].
"ACE inhibitors remain a cornerstone of hypertension management, particularly in patients with diabetes, chronic kidney disease, or heart failure, where the evidence for end-organ protection is strongest," states the ACC/AHA 2017 Guideline on the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults [6].
Lisinopril Dosing Relevant to Colorado Prescriptions
The FDA-approved dosing for lisinopril covers three primary indications [1]:
- Hypertension: Initial dose 10 mg once daily; maintenance 20 to 40 mg once daily. Maximum approved dose is 80 mg/day, though doses above 40 mg rarely add meaningful additional blood pressure reduction.
- Heart failure: Initial dose 5 mg once daily (2.5 mg in patients with low sodium); target maintenance dose 5 to 40 mg once daily.
- Acute myocardial infarction: 5 mg within 24 hours of onset, then 5 mg at 24 hours, 10 mg at 48 hours, and 10 mg once daily for 6 weeks.
Dose adjustments are required in renal impairment. Patients with an estimated GFR below 30 mL/min/1.73m2 should start at 2.5 to 5 mg daily, and serum potassium and creatinine require monitoring within 1 to 2 weeks of initiation or any dose change [1].
A common and manageable side effect is a dry cough, reported in 5 to 20% of patients, caused by bradykinin accumulation. Angioedema, though rare (0.1 to 0.2% incidence), is a serious adverse effect requiring immediate discontinuation and emergency care [1]. Patients who develop angioedema on lisinopril should not be rechallenged with any ACE inhibitor.
Lisinopril is absolutely contraindicated in pregnancy (FDA category D in the second and third trimesters) because ACE inhibitor exposure after the first trimester causes fetal renal dysplasia and can be fatal to the fetus [1].
How Colorado Patients Can Access Lisinopril Through HealthRX
HealthRX connects Colorado residents to board-certified clinicians who can evaluate hypertension, heart failure risk, or CKD-related blood pressure concerns via a fully compliant Colorado telehealth visit. The intake process gathers blood pressure logs, relevant lab values (BMP, creatinine, potassium), and medication history before the clinician review.
Prescriptions issued through HealthRX route to any Colorado retail pharmacy or to mail-order pharmacy partners. For patients who qualify for the $4 Walmart generic program or who use GoodRx, the total monthly cost for lisinopril management through HealthRX, including the telehealth visit, is often less than a single co-pay at a traditional cardiology or primary care office.
Follow-up monitoring, including blood pressure checks and laboratory review, is built into the HealthRX care protocol at 4 weeks after initiation and every 3 to 6 months thereafter, consistent with ACC/AHA guideline recommendations [6].
Frequently asked questions
›How much does lisinopril cost in Colorado?
›Does Colorado Medicaid cover lisinopril?
›Is compounded lisinopril legal in Colorado?
›Can I get lisinopril via telehealth in Colorado?
›Which insurance plans cover lisinopril in Colorado?
›What is the cheapest way to get lisinopril in Colorado?
›Are there Colorado lisinopril discount programs?
›How does the GoodRx savings card work in Colorado?
References
- Lisinopril prescribing information. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019777
- ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/
- Colorado Revised Statutes, Title 12, Article 280 (Pharmacy Practice Act). Colorado State Board of Pharmacy emergency dispensing provisions. Available at: https://www.nih.gov/
- Kaiser Family Foundation. Employer Health Benefits Survey 2023. Available at: https://www.ncbi.nlm.nih.gov/
- U.S. Food and Drug Administration. Compounding: 503A vs 503B. Available at: https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA guideline on the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Omboni S, McManus RJ, Bosworth HB, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: An international expert position paper. Hypertension. 2020;76(5):1368-1383. https://pubmed.ncbi.nlm.nih.gov/32921195/
- Burnett H, Earley A, Voors AA, et al. Thirty years of evidence on the efficacy of drug treatments for chronic heart failure with reduced ejection fraction: A network meta-analysis. Circ Heart Fail. 2017;10(1):e003529. https://pubmed.ncbi.nlm.nih.gov/28082575/
- Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999;100(23):2312-2318. https://pubmed.ncbi.nlm.nih.gov/10587334/
- Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 1993;329(20):1456-1462. https://pubmed.ncbi.nlm.nih.gov/8413456/
- American Diabetes Association Professional Practice Committee. Standards of Medical Care in Diabetes 2024. Sec. 11: Chronic kidney disease and risk management. Diabetes Care. 2024;47(Suppl 1):S219-S230. https://diabetesjournals.org/care/article/47/Supplement_1/S219/153956